4//SEC Filing
SANG CHARLES 4
Accession 0001209191-20-009863
CIK 0001478320other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:05 AM ET
Size
10.4 KB
Accession
0001209191-20-009863
Insider Transaction Report
Form 4
SANG CHARLES
Sr VP, Clinical Diagnostics
Transactions
- Award
Stock Option (Right to Buy)
2020-02-13+40,000→ 40,000 totalExercise: $31.71Exp: 2030-02-13→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The options vest with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780656
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 7:05 AM ET
- Size
- 10.4 KB